TM was remarkably nontoxic when ceruloplasmin was lowered to 10–20% of baseline levels for up to 17 months of treatment, and the only drug-related toxicity observed was mild anemia, which was easily reversible with adjustment of the TM dose to bring the ceruloplasmin level to the desired target [40]. Here, CP is linked to anemia (phenotype).